Background The current standard of care for the systemic treatment of metastatic hormone
sensitive prostate cancer (mHSPC) includes androgen deprivation therapy (ADT) with either …

Importance The US Preventive Services Task Force (USPSTF) has recommended against
routine prostate-specific antigen (PSA)–based prostate cancer (PCa) screening, initially for …

Background In international guidelines, germline genetic testing is recommended for
patients with metastatic prostate cancer. Before undergoing germline genetic testing, these …

Background and aims PSA testing practice results in a large number of unnecessary
prostate biopsies and the overdiagnosis of clinically insignificant prostate cancer (PCa). The …

Background: Outcomes of castration-sensitive prostate cancer (CSPC) have improved owing
to new therapies and early treatment, previously reserved for castration-resistant disease …

This is a continuation of our research into the development of novel biosensing technologies
for early diagnostics of prostate cancer (PCa). The existing PCa diagnostics based on PSA …

Abstract Purpose A Gleason score≥ 8, metastatic tumor burden, and visceral metastasis are
known prognostic factors for patients with metastatic hormone-sensitive prostate cancer …

Background Attempts to reduce prostate cancer (PC) mortality require an understanding of
temporal changes in the characteristics of men with lethal PC. Objective To describe the …

• Black people with prostate cancer face a complex interplay of structural barriers such as
inadequate health education, underrepresentation in clinical trials and reduced access to …

• Les hommes noirs atteints d'un cancer de la prostate font face à l'interaction complexe de
divers facteurs structurels et obstacles tels qu'une littératie médicale insuffisante, une …